AUSTIN, Texas, Nov. 8, 2021 /PRNewswire/ -- Spindletop
Health Acquisition Corp. (the "Company"), today announced the
closing of its initial public offering of 23,000,000 units at a
price of $10.00 per unit, including
3,000,000 units issued pursuant to the exercise in full by the
underwriters of their over-allotment option. The units are listed
on the NASDAQ Stock Market and began trading under the ticker
symbol "SHCAU" on November 4, 2021.
Each unit consists of one share of the Company's Class A common
stock and one-half of one redeemable warrant. Each whole warrant
entitles the holder thereof to purchase one share of Class A common
stock at a price of $11.50 per share.
Only whole warrants will be exercisable. Once the securities
comprising the units begin separate trading, the Company expects
that its Class A common stock and warrants will be listed on NASDAQ
under the symbols ''SHCA'' and ''SHCAW,'' respectively.
The Company was formed for the purpose of effecting a merger,
capital stock exchange, asset acquisition, stock purchase,
reorganization, or similar business combination with one or more
businesses. The Company's efforts to identify a prospective target
business will not be limited to a particular industry or geographic
region, although it intends to focus on identifying, acquiring and
building an undervalued, growth-oriented company in the healthcare
services sector.
Barclays and Stifel acted as joint book running managers.
The public offering was made only by means of a prospectus.
Copies of the final prospectus relating to the offering may be
obtained from Barclays Capital Inc., c/o Broadridge Financial
Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, by telephone:
1-888-603-5847 or by email: Barclaysprospectus@broadridge.com; or
Stifel, Nicolaus, & Company, Incorporated, 1 South Street,
15th Floor, Baltimore,
Maryland 21202, Attn: Prospectus Department, or by emailing
syndprospectus@stifel.com.
Registration statements relating to the securities became
effective on November 3, 2021. This
press release shall not constitute an offer to sell or the
solicitation of an offer to buy, nor shall there be any sale of
these securities in any state or jurisdiction in which such offer,
solicitation, or sale would be unlawful prior to registration or
qualification under the securities laws of any such state or
jurisdiction.
Forward-Looking Statements
This press release contains statements that constitute
"forward-looking statements," including with respect to the
proposed initial public offering and the anticipated use of the net
proceeds thereof. No assurance can be given that the net proceeds
of the offering will be used as indicated. Forward-looking
statements are subject to numerous conditions, many of which are
beyond the control of the Company, including those set forth in the
Risk Factors section of the Company's registration statement and
prospectus for the Company's offering filed with the U.S.
Securities and Exchange Commission (the "SEC"). Copies of these
documents are available on the SEC's website, www.sec.gov. The
Company undertakes no obligation to update these statements for
revisions or changes after the date of this release, except as
required by law.
Contact:
Spindletop Health Acquisition Corp.
512.961.4633
info(at)spindletophealth.com
View original
content:https://www.prnewswire.com/news-releases/spindletop-health-acquisition-corp-announces-closing-of-230-million-initial-public-offering-301419075.html
SOURCE Spindletop Health Acquisition Corp.